Seniors still benefit from allergy shots

Written by Mohan Garikiparithi
Published on

Seniors still benefit from allergy shotsA new study found that seniors still benefit from receiving allergy shots. The study consisted of 60 seniors suffering from hay fever. The participants received either an allergy shot or a placebo.

The allergy shot group saw a 55 percent reduction in allergy symptoms and a 64 percent drop in the use of allergy medication.

Hay fever, particularly in seniors, can be challenging to diagnose and treat due to complications from other coexisting health problems. The researchers found that seniors’ aging immune system doesn’t reduce the effectiveness of allergy shots.

Dr. Ira Finegold, past president of the American College of Allergy, Asthma and Immunology, said in a news release, “Older people who suffer from hay fever may have health challenges that younger people do not. Hay fever is often ignored in older patients as a less significant health problem because of diseases such as asthma, coronary heart disease, depression, and high blood pressure. Also, some baby boomers might not realize they have allergies, and their physicians might not suggest allergy shots. The research indicated that allergy shots were extremely effective for this group.”
The findings were published in the Annals of Allergy, Asthma and Immunology.


Source:
http://consumer.healthday.com/senior-citizen-information-31/senior-citizen-news-778/to-come-707783.html

Advertisement

On any matter relating to your health or well-being, please check with an appropriate health professional. No statement herein is to be construed as a diagnosis, treatment, preventative, or cure for any disease, disorder or abnormal physical state. The statements herein have not been evaluated by the Foods and Drugs Administration or Health Canada. Dr. Marchione and the doctors on the Bel Marra Health Editorial Team are compensated by Bel Marra Health for their work in creating content, consulting along with formulating and endorsing products.

Exit mobile version